PLX-4720/PLX4720

 Home / Products / Inhibitors / B-Raf inhibitors / PLX-4720/PLX4720
PLX-4720/PLX4720

PLX-4720/PLX4720

Cat.No.ABP000428 Chemical NamePLX-4720/PLX4720 CAS918505-84-7 MDL: MFCD14635203 MolFormulaC17H14ClF2N3O3S MolWeight413.826 Purity >98%

Chemical Name : PLX-4720/PLX4720

CAS : 918505-84-7

Synonyms: N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide

Solubility:DMSO

Storage:at -20℃ 2 years

Biologieal

PLX4720, a 7-azaindole derivative that inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochemical and cellular assays. PLX4720 preferentially inhibits the active B-RafV600E kinase compared with a broad spectrum of other kinases and potent cytotoxic effects are also exclusive to cells bearing the V600E allele (GI50<1.7uM, while other wild cell GI50>10uM).Consistent with the high degree of selectivity, ERK phosphorylation is potently inhibited by PLX4720 in B-RafV600E -bearing tumor cell lines but not in cells lacking oncogenic B-Raf.In B-RafV600E -dependent tumor xenograft models, orally dosed PLX4720 causes significant tumor growth delays, including tumor regressions, without evidence of toxicity.

Reference

1.Tsai J, et al. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3041-6.

Enquiry